NLRP3 activity has been extensively implicated in the pathophysiology of several metabolic disorders including obesity, type 2 diabetes, gout, and CVD, all of which occur more frequently in BD [82]. Here, NLRP3 is linked to obesity due to melanocortin 4 receptor deficiency.